Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Navigator program aims to bridge support gap for women of color with advanced breast cancer

NCT ID NCT06405828

First seen Nov 06, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This pilot study tests whether a community navigator can help Black and Latina women with metastatic breast cancer access supportive care and community resources. Participants receive six coaching sessions and monthly check-ins over 16 weeks. The study will measure feasibility, acceptability, and changes in distress and symptom burden.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mount Sinai Hospital

    RECRUITING

    New York, New York, 10029, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Community navigator-led supportive care coaching and resource linkage

What this could lead to

If successful, this could show that a navigator program improves access to supportive services and reduces distress for underserved women with advanced breast cancer.

What could go wrong

This is a small pilot study (67 participants) focused on feasibility, not proof of effectiveness. Results may not apply to other groups or settings.

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.